THE ROLE OF THE PPARG2 GENE PRO12ALA POLYMORPHIC MARKER IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY

dc.contributor.authorJabbarov O.O
dc.contributor.authorSapayeva Z.A
dc.date.accessioned2025-12-31T15:35:54Z
dc.date.issued2021-12-30
dc.description.abstractThis article presents the results of a study of 129 patients with type 2 diabetes and 110 healthy people to determine whether polymorphic Pro12Ala markers of the PPARG2 gene are associated with the development of diabetic nephropathy. Patients in the main group: 65 patients with a disease duration of up to 10 years, without diabetic nephropathy (33 patients) and with diabetic nephropathy (32 patients), 64 patients with diabetes lasting more than 10-20 years, with no diabetic nephropathy (31 patients ) and diabetic nephropathy (33 patients). Genotyping was carried out by polymerase chain reaction
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/425
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/48812
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/425/404
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 5 (2021): WBPH; 105-107
dc.source2749-3644
dc.subjectDiabetic nephropathy
dc.subjectdiabetes mellitus
dc.subjectPPARG2 gene
dc.subjectpolymorphism
dc.titleTHE ROLE OF THE PPARG2 GENE PRO12ALA POLYMORPHIC MARKER IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
oo_2021_the_role_of_the_pparg2_gene_pro12ala_pol.pdf
item.page.filesection.size
172.31 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections